Cargando…
In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
Breast cancer is the second most common cancer and the most frequent cancer in women worldwide. Recent improvements in early detection and effective adjuvant chemotherapies have improved the survival of breast cancer patients. Even with initial disease remission, one-third of all breast cancer patie...
Autores principales: | Oh, Keunhee, Lee, Dong-Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for Laboratory Animal Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645605/ https://www.ncbi.nlm.nih.gov/pubmed/29046702 http://dx.doi.org/10.5625/lar.2017.33.3.256 |
Ejemplares similares
-
The key role of microRNA-766 in the cancer development
por: Gupta, Jitendra, et al.
Publicado: (2023) -
MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1
por: Choi, Sujin, et al.
Publicado: (2023) -
Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766
por: Shao, Cunhua, et al.
Publicado: (2020) -
MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer
por: Zhang, Xingzeng, et al.
Publicado: (2017) -
MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
por: Tang, Wentao, et al.
Publicado: (2018)